# DIBBS #SPE2DP-26-T-5353

DLA request for 22 bottles of moxifloxacin hydrochloride tablets

**Posted:** September 30, 2026
**Respond By:** October 05, 2026
**Identifier:** SPE2DP-26-T-5353
**NAICS:** 424210

DLA Troop Support is seeking 22 bottles of moxifloxacin hydrochloride tablets for pharmaceutical supply requirements.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA.
- **OEMs / approved sources:** **Teva Pharmaceuticals USA, Inc.** (NDC 00093-7387-56) and **Rising Pharma Holdings, Inc.** (NDC 57237-0156-30).
- **Products requested:** Moxifloxacin hydrochloride 400 mg tablets, 30 tablets per bottle, NSN 6505-01-503-4772.
  - 20 bottles under one line item.
  - 2 bottles under a separate line item.
- **Notable requirements:** FDA-regulated product with a 36-month non-extendable shelf life. Store at controlled room temperature and protect from high humidity. Delivery is FOB destination within 20 days after order to separate Navy destinations.

### Description

MOXIFLOXACIN HYDROC (QTY: 2, NSN: 6505-01-503-4772, Purchase Request: 7018559038)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 20, NSN: 6505-01-503-4772, Purchase Request: 7016495604)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5353)